Drug: riociguat (adempas) 1MG tab, 90/bottle, NCC #50419-0251-01

Ended Awarded Last action

Contract number
VA26017J1807
Awardee
Awarding agency
Obligated
$135,460

Award facts

Contract value 60% obligated
  • $135,459.64 Current, with exercised options
  • $225,918.94 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Wayne, NJ, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00006 -$232
Funding Only Action P00004 $39,197
Funding Only Action P00003 · Drug: riociguat (adempas) 1MG tab, 90/bottle, NCC #50419-0251-01 closeout of base period 663C75376 -$12,057
Exercise an Option P00002 · Drug: riociguat (adempas) 1MG tab, 90/bottle, NCC #50419-0251-01 PU OY1 $90,459
Change Order P00001 $0
Original award $18,092

About this award

This is a Firm Fixed Price contract awarded to Bayer Healthcare Pharmaceuticals Inc. by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 20. The contract is a Blanket Purchase Agreement (BPA) Call under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) with a potential value of $225,918.94. Bayer Healthcare Pharmaceuticals Inc. will provide the drug Riociguat (Adempas) 1mg tablets to the VA. This contract does not have a small business set-aside. Bayer Healthcare Pharmaceuticals Inc. is a foreign-owned, for-profit organization that has provided various pharmaceutical products to the VA and the Defense Logistics Agency (DLA) through previous prime contract awards.

Quick answers

Who was awarded contract VA26017J1807?

VA26017J1807 was awarded to Bayer Healthcare Pharmaceuticals Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on July 19, 2017.

How much is contract VA26017J1807 worth?

The government has obligated $135,460 on VA26017J1807. Its potential value, with all options, is $225,919.

Is contract VA26017J1807 an order under another contract?

Yes. VA26017J1807 is a BPA call under V797P2202D-VA797P14A0013, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract VA26017J1807 competed?

The extent of competition for VA26017J1807 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award